María Eugenia Toledo-Romaní, Mayra García-Carmenate, Carmen Valenzuela-Silva, Waldemar Baldoquín-Rodríguez, Marisel Martínez-Pérez, Meiby Rodríguez-González, . . . Vicente Verez-Bencomo. (2023). Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: A double-blind, randomised, placebo-controlled phase 3 clinical trialResearch in context. Elsevier.
Chicago Style (17th ed.) CitationMaría Eugenia Toledo-Romaní, et al. Safety and Efficacy of the Two Doses Conjugated Protein-based SOBERANA-02 COVID-19 Vaccine and of a Heterologous Three-dose Combination with SOBERANA-Plus: A Double-blind, Randomised, Placebo-controlled Phase 3 Clinical TrialResearch in Context. Elsevier, 2023.
MLA (9th ed.) CitationMaría Eugenia Toledo-Romaní, et al. Safety and Efficacy of the Two Doses Conjugated Protein-based SOBERANA-02 COVID-19 Vaccine and of a Heterologous Three-dose Combination with SOBERANA-Plus: A Double-blind, Randomised, Placebo-controlled Phase 3 Clinical TrialResearch in Context. Elsevier, 2023.